Aurora Cannabis (TSE:ACB) Reaches New 52-Week Low – Here’s What Happened

Aurora Cannabis Inc. (TSE:ACBGet Free Report) shares reached a new 52-week low during trading on Tuesday . The stock traded as low as C$3.75 and last traded at C$3.84, with a volume of 284792 shares. The stock had previously closed at C$3.87.

Analyst Ratings Changes

A number of research analysts recently weighed in on the stock. TD reduced their price objective on shares of Aurora Cannabis from C$10.00 to C$8.00 and set a “buy” rating for the company in a research note on Friday, June 12th. Canaccord Genuity Group dropped their target price on Aurora Cannabis from C$6.50 to C$5.00 and set a “buy” rating on the stock in a research report on Tuesday, June 30th. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Aurora Cannabis currently has a consensus rating of “Buy” and a consensus target price of C$7.17.

Get Our Latest Stock Analysis on Aurora Cannabis

Aurora Cannabis Stock Up 1.3%

The company has a current ratio of 5.94, a quick ratio of 2.48 and a debt-to-equity ratio of 4.66. The firm has a market cap of C$238.48 million, a PE ratio of -1.80 and a beta of 0.27. The stock has a fifty day simple moving average of C$4.47 and a two-hundred day simple moving average of C$4.96.

Aurora Cannabis (TSE:ACBGet Free Report) last announced its quarterly earnings results on Thursday, June 11th. The company reported C($0.99) earnings per share for the quarter. Aurora Cannabis had a negative net margin of 12.13% and a negative return on equity of 7.25%. The company had revenue of C$38.01 million for the quarter. As a group, sell-side analysts expect that Aurora Cannabis Inc. will post -0.22 EPS for the current fiscal year.

Aurora Cannabis Company Profile

(Get Free Report)

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

See Also

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.